BIO Announces Keynote Speakers for BIO India International Conference

WASHINGTON, D.C. and HYDERABAD, INDIA (September 6, 2011) - The Biotechnology Industry Organization (BIO) today announces the keynote speakers for the BIO India International Conference to be held September 21 - 22 at the Hyderabad International Convention Centre in Hyderabad, India. This exclusive forum will bring together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India’s emerging biotech sector.

BIO India attendees will have the opportunity to hear keynote addresses both days of the conference. Wednesday, September 21^st, will feature a keynote luncheon with G.V. Prasad, Vice Chairman & CEO, Dr. Reddy’s Laboratories, Ltd andAaron Schacht, Executive Director & COO, Global External R&D, Eli Lilly & Company. Thursday, September 22^ndwill kick the day off with a keynote address by Glenn Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals.

“The Indian biotech and pharmaceutical space is one of the most active and rapidly growing in the world.  Our distinguished keynote speakers will provide insights on how research programs are developing, deals are being done, and the industry is establishing itself as a global player,” said Alan Eisenberg, Executive Vice President, BIO.   “These leaders have been very directly engaged in establishing R&D programs and collaborations that will help define India’s world class industry.”

BIO India 2011 will feature BIO One-on-One Partnering, Plenary and Panel Sessions, Company Presentations and Exhibiting and Networking Opportunities. Through the various meeting features, senior executives from the industry’s most important biotech and pharma companies will be seeking Indian partners who can provide high-quality contract research, manufacturing and clinical trials support and are looking to partner on discovery and development deals.

The 2011 BIO India conference will feature industry leaders discussing innovation and financing, global biopharma and examining a high-profile deal between a multi-national pharma and an Indian biotech company.  Panel sessions highlight the latest issues and trends related to doing business in India.

For more information on BIO India, please visit http://www3.bio.org/bioindia/?q=bioindia/.